Sources | Names Used |
---|---|
CTRPv2 | BRD-K16147474 |
PharmacoGx | BRD-K16147474 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAS2R9 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ABLIM1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | APOLD1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | STARD3NL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | MYO1D | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RNF4 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | IGF2BP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | HBP1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | RALGPS1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | MAP2K7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |